Aurora Cannabis (TSE:ACB) Trading 8.2% Higher

Shares of Aurora Cannabis Inc. (TSE:ACB) shot up 8.2% during mid-day trading on Thursday . The stock traded as high as C$8.72 and last traded at C$8.70. 904,213 shares were traded during mid-day trading, a decline of 26% from the average session volume of 1,221,178 shares. The stock had previously closed at C$8.04.

Analyst Ratings Changes

Several brokerages recently issued reports on ACB. Jefferies Financial Group dropped their price target on Aurora Cannabis from C$6.12 to C$4.95 and set a “hold” rating on the stock in a research report on Tuesday, February 27th. Canaccord Genuity Group raised Aurora Cannabis from a “hold” rating to a “buy” rating and set a C$0.80 price objective on the stock in a report on Friday, February 9th. Finally, CIBC lowered their price objective on Aurora Cannabis to C$6.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st.

Aurora Cannabis Price Performance

The company has a 50 day moving average price of C$5.39 and a 200 day moving average price of C$2.28. The firm has a market cap of C$483.77 million, a PE ratio of -0.11 and a beta of 2.83. The company has a current ratio of 3.79, a quick ratio of 2.48 and a debt-to-equity ratio of 18.51.

Aurora Cannabis (TSE:ACB) last announced its quarterly earnings results on Thursday, February 8th. The company reported C($0.20) EPS for the quarter, missing the consensus estimate of C($0.10) by C($0.10). Aurora Cannabis had a negative return on equity of 137.28% and a net margin of 151.71%. The firm had revenue of C$72.61 million for the quarter, compared to analysts’ expectations of C$63.50 million. On average, sell-side analysts expect that Aurora Cannabis Inc. will post -0.22 EPS for the current year.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.